•
Astra Biotech, a developer of single molecule immunodiagnostic technology based in Suzhou, has reportedly raised “tens of millions” of renminbi in a pre-Series B financing round. The round was led by Zheng Xuan Investment, with participation from BioTrack Capital, Chuangshou Equity Investment, and others. The funds will be utilized to…